Biomerica (BMRA) Operating Expenses (2010 - 2026)

Biomerica's Operating Expenses history runs 17 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 2.03% year-over-year to $1.3 million; the TTM figure through Feb 2026 stood at $5.5 million (down 5.53% YoY), while the FY2025 annual figure was $5.6 million, down 19.25% from the prior year.
• Operating Expenses came in at $1.3 million for Q1 2026 at Biomerica, down from $1.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.4 million in Q2 2022 to a low of $1.2 million in Q1 2025.
• A 5-year average of $1.7 million and a median of $1.7 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 38.83% in 2022 and plunged 33.6% in 2025, its largest moves.
• Biomerica's Operating Expenses stood at $2.0 million in 2022, then fell by 4.21% to $1.9 million in 2023, then retreated by 26.02% to $1.4 million in 2024, then decreased by 0.42% to $1.4 million in 2025, then decreased by 11.94% to $1.3 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $1.3 million, $1.4 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison